View Older Stories View More Recent Stories
-
IDEAYA Announces Pricing of Public Offering
-
2Q24 U.S. biotech earnings preview
-
IDEAYA Biosciences (IDYA) Announces Proposed $200M Share and Warrant Offering
-
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Walmart vs. Target stock: Which is a better investment?
-
Cooper Equipment Rentals Closes Offering of C$250 million Senior Unsecured Notes
-
Strengthening Global Ties: BTIG Welcomes Flavio Paparella to Emerging Markets Fixed Income Team
-
TWFG Announces Launch of Initial Public Offering
-
Ryan to Acquire Altus Group’s Property Tax Services Business
-
Pershing Square USA, Ltd. Announces Launch of IPO Roadshow
-
Maple Leaf Foods to unlock value as purpose-driven consumer packaged goods business, spinning off its world-leading pork business
-
RBC Capital Downgrades Morphic Therapeutic (MORF) to Sector Perform
-
RBC Capital Reiterates Outperform Rating on Spire Healthcare Group Plc (SPI:LN) (SRRHF)
-
Julius Baer Group Ltd. (BAER:SW) (JBAXY) PT Lowered to CHF63 at RBC Capital
-
RBC Capital Upgrades Naturgy Energy Group (NTGY:SM) (GASNY) to Sector Perform
-
RBC sees a buying opportunity in this solar stock
-
SolarEdge Technologies (SEDG) PT Lowered to $37 at RBC Capital
-
MORF Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Morphic Holding to Eli Lilly
-
MORF Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Morphic Holding to Eli Lilly
-
Exxon Mobil signals second-quarter earnings hit from refining margins, natural gas prices
-
RBC Capital Reiterates Outperform Rating on First Solar (FSLR), 'Buying Opportunity'
-
RBC Capital Reiterates Outperform Rating on Santos Ltd. (STO:AU) (SSLZY)
-
RBC Capital Upgrades GDS Holdings (GDS) to Outperform
-
RBC Capital Downgrades Stella-Jones Inc. (SJ:CN) (STLJF) to Sector Perform
-
Schroders Plc (SDR:LN) (SHNWF) PT Lowered to GBP3.65 at RBC Capital
-
RBC Capital Upgrades Melrose Industries PLC (MRO:LN) (MLSPF) to Outperform
-
Adidas AG (ADS:GR) (ADDYY) Mentioned Positively at RBC Capital, 'we remain positive on the prospect of broadening growth'
-
RBC Capital Reiterates Outperform Rating on Agnico-Eagle Mines Ltd. (AEM)
-
Teck Announces Cash Tender Offers for up to US$1.25 Billion of Debt Securities
-
Britain's Labour Party cruises to election victory
-
HBC, Parent of Saks Fifth Avenue, to Acquire Neiman Marcus Group for $2.65 Billion and Establish Saks Global, a Technology-Powered Luxury Retail Company
-
Aritzia Inc (ATZ:CN) (ATZAF) PT Raised to Cdn$46 at RBC Capital
-
Xero Limited (XRO:AU) (XROLF) PT Raised to AUD160 at RBC Capital
-
RBC Capital Reiterates Sector Perform Rating on Puma SE (PUM:GR) (PMMAF)
-
Pandora A/S (PNDORA:DC) (PANDY) PT Lowered to DKK9.20 at RBC Capital
-
RBC Capital Starts Ibstock Plc. (IBST:LN) (IBJHF) at Outperform
-
RBC Capital Starts Forterra Plc. (FORT:LN) (FTTRF) at Outperform
-
RBC Capital on Constellation Brands (STZ): 'How does this quarter impact our thesis? No material changes'
-
Waystar (WAY) initiated at Buy at Barclays and RBC, upside potential up to 25%
-
RBC Capital Reiterates Sector Perform Rating on SM Energy (SM)
-
RBC Capital Reiterates Outperform Rating on Northern Oil and Gas (NOG)
-
RBC Capital Reiterates Outperform Rating on Avid Bioservices (CDMO)
-
RBC Capital Reiterates Outperform Rating on Rollins (ROL)
-
RBC Capital Reiterates Outperform Rating on CoStar Group (CSGP)
-
RBC Capital Starts Intuit (INTU) at Outperform
-
RBC Capital Upgrades Mattr Ltd (MATR:CN) to Outperform
-
RBC Capital Upgrades L'Oreal SA (OR:FP) (LRLCY) to Sector Perform
-
Form MA-I RBC Capital Markets,
-
Eli Lilly Alzheimer's drug approved by US FDA
-
RBC Capital on Pacira Pharmaceuticals (PCRX): 'regulatory approval of the generic form is just one piece of a larger puzzle'
